Eli Eyal

Eli Eyal is an experienced biostatistician with a strong background in the pharmaceutical industry. Currently serving as a Biostatistician at Clexio Biosciences since July 2019, Eli previously held the position of Director of Biostatistics at Pluristem Therapeutics from July 2017 to June 2019. Prior to that, Eli was the Chief Biostatistician at Teva Pharmaceuticals for 25 years, from May 1992 to June 2017. Eli Eyal holds an M.Sc in Applied Statistics and a B.Sc in Mathematics and Operations Research, both from Tel Aviv University.